TRIM11 and neoplasm: Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion (CMTCT), first reported by Cellier et al in 2018,1 is an intradermal, nonpigmented tumor with melanocytic differentiation and characteristic CRTC1::TRIM11 fusion.